These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 36033451)

  • 1. Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?
    Gonvers S; Tabrizian P; Melloul E; Dormond O; Schwartz M; Demartines N; Labgaa I
    Front Oncol; 2022; 12():940473. PubMed ID: 36033451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erratum: Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?
    Frontiers Production Office
    Front Oncol; 2023; 13():1180615. PubMed ID: 37007082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Liquid Biopsy in Hepatocellular Carcinoma Prognostication.
    Labgaa I; Villanueva A; Dormond O; Demartines N; Melloul E
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
    Ye Q; Ling S; Zheng S; Xu X
    Mol Cancer; 2019 Jul; 18(1):114. PubMed ID: 31269959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma.
    Wu X; Li J; Gassa A; Buchner D; Alakus H; Dong Q; Ren N; Liu M; Odenthal M; Stippel D; Bruns C; Zhao Y; Wahba R
    Int J Biol Sci; 2020; 16(9):1551-1562. PubMed ID: 32226301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
    Li J; Han X; Yu X; Xu Z; Yang G; Liu B; Xiu P
    J Exp Clin Cancer Res; 2018 Sep; 37(1):213. PubMed ID: 30176913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria.
    Amado V; Rodríguez-Perálvarez M; Ferrín G; De la Mata M
    J Hepatocell Carcinoma; 2019; 6():1-10. PubMed ID: 30613572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient Selection for Downstaging of Hepatocellular Carcinoma Prior to Liver Transplantation-Adjusting the Odds?
    Seehofer D; Petrowsky H; Schneeberger S; Vibert E; Ricke J; Sapisochin G; Nault JC; Berg T
    Transpl Int; 2022; 35():10333. PubMed ID: 35529597
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
    Court CM; Hou S; Winograd P; Segel NH; Li QW; Zhu Y; Sadeghi S; Finn RS; Ganapathy E; Song M; French SW; Naini BV; Sho S; Kaldas FM; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG
    Liver Transpl; 2018 Jul; 24(7):946-960. PubMed ID: 29624843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular cancer selection systems and liver transplantation: from the tower of babel to an ideal comprehensive score.
    Lerut J; Foguenne M; Lai Q
    Updates Surg; 2021 Oct; 73(5):1599-1614. PubMed ID: 34003479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of hepatocellular carcinoma grade by needle biopsy is unreliable for liver transplant candidate selection.
    Court CM; Harlander-Locke MP; Markovic D; French SW; Naini BV; Lu DS; Raman SS; Kaldas FM; Zarrinpar A; Farmer DG; Finn RS; Sadeghi S; Tomlinson JS; Busuttil RW; Agopian VG
    Liver Transpl; 2017 Sep; 23(9):1123-1132. PubMed ID: 28688158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma.
    Yang PC; Ho CM; Hu RH; Ho MC; Wu YM; Lee PH
    World J Hepatol; 2016 Nov; 8(31):1309-1317. PubMed ID: 27872682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic Science with Preclinical Models to Investigate and Develop Liquid Biopsy: What Are the Available Data and Is It a Fruitful Approach?
    Cena B; Melloul E; Demartines N; Dormond O; Labgaa I
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biopsy derived circulating tumor cells and circulating tumor DNA as novel biomarkers in hepatocellular carcinoma.
    Temraz S; Nasr R; Mukherji D; Kreidieh F; Shamseddine A
    Expert Rev Mol Diagn; 2022 May; 22(5):507-518. PubMed ID: 35758097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy.
    Maravelia P; Silva DN; Rovesti G; Chrobok M; Stål P; Lu YC; Pasetto A
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid Biopsy Using Cell-Free or Circulating Tumor DNA in the Management of Hepatocellular Carcinoma.
    Lyu X; Tsui YM; Ho DW; Ng IO
    Cell Mol Gastroenterol Hepatol; 2022; 13(6):1611-1624. PubMed ID: 35183803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma.
    Tabrizian P; Holzner ML; Mehta N; Halazun K; Agopian VG; Yao F; Busuttil RW; Roberts J; Emond JC; Samstein B; Brown RS; Najjar M; Chapman WC; Doyle MM; Florman SS; Schwartz ME; Llovet JM
    JAMA Surg; 2022 Sep; 157(9):779-788. PubMed ID: 35857294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma.
    Ahn JC; Teng PC; Chen PJ; Posadas E; Tseng HR; Lu SC; Yang JD
    Hepatology; 2021 Jan; 73(1):422-436. PubMed ID: 32017145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine.
    Moldogazieva NT; Zavadskiy SP; Terentiev AA
    Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver Transplantation for Hepatocellular Carcinoma: How Should We Improve the Thresholds?
    Shimamura T; Goto R; Watanabe M; Kawamura N; Takada Y
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.